Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,395,200
+$2,247,200 QoQ
Shares Held
1,060,000
0.0% QoQ
Ownership
0.581%
of shares outstanding
% of Portfolio
4.83%
of 13F equity value
Holder Rank
#28
of 239 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Knott David M Jr holds $14,775,371 across 2 Drug Manufacturers - Specialty & Generic names. XERS ranks #1 (56.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
1,060,000 | $8,395,200 | |
| 2 | ALKS |
Alkermes plc.
|
121,759 | $6,380,171 |
All Filings in XERS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,395,200 | 1,060,000 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $6,148,000 | 1,060,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,614,500 | 970,000 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $8,262,100 | 1,015,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,950,200 | 1,060,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,093,900 | 1,110,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,390,000 | 1,000,000 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,850,000 | 1,000,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,845,000 | 820,000 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,326,000 | 600,000 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $911,588 | 387,910 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||